KATHERINE DENNIS: Open Payments
NPI 1053918847 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 34 payments from 10 companies in 2025. Trend: 2023 $1,046 · 2024 $1,009 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $112 |
| Novo Nordisk Inc | 6 | $102 |
| Exact Sciences Corporation | 4 | $85 |
| Lilly USA, LLC | 4 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| SANOFI-AVENTIS U.S. LLC | 1 | $51 |
| Amgen Inc. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
Products named: ELIQUIS, Cologuard Collection Kit, XIFAXAN, Wegovy, MOUNJARO, TZIELD, OTEZLA, Ozempic.
Industry payments across MD — which companies pay providers there.
